Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment.
PubMed
2023/03/14 发表Cancer MedQ2 · IF 3.5(JCR 2025)
对曲妥珠单抗反应良好的 HER2 阳性胃癌以细胞周期相关基因改变和 CD3 - CD57 + NK 细胞浸润增加为特征。